For Immediate Release – January 11, 2018
TCG and MedSurgPI, two North Carolina-based life sciences consulting firms, today announced the formation of a strategic partnership to provide highly complementary skills in support of their pharmaceutical, biotechnology and medical device client companies. TCG offers strategic transaction advisory services as well as experienced C-level executives acting as interim operational and commercial managers to grow life sciences companies. MedSurgPI provides its clients with highly experienced clinician-executives acting as medical officers for strategic planning, product development, medical monitoring, safety and pharmacovigilance. The ability of the two firms working together to support clients in executing their business objectives across their commercial and medical operations makes the partnership especially attractive.
To learn more about this partnership, you may contact TCG’s Ken West at phone (919) 941-0700 x108 or E-mail email@example.com or contact MedSurgPI’s Peter Johnson, MD at (919) 807-9132.
Founded in 1998, TCG serves life science companies, including medical device, pharmaceutical, and biotechnology companies from its headquarters in the Research Triangle Park region of North Carolina, USA and offices in Heidelberg, Germany. TCG leads and advises transactions, including licensing, strategic partnerships, distribution agreements, asset sales, financings, and acquisitions. TCG also provides interim management, when an experienced executive is needed for a critical project, to enter a new market, to develop a new strategy, or to refocus a company. TCG’s approach is different from other firms in that only senior TCG partners, with over 25 years of life science industry experience, lead assignments. TCG has developed experience in bringing European based companies commercialize their products in the US. TCG has successfully completed dozens of life science projects and assignments.
Founded in 2015 by two highly experienced physician-executives, MedSurgPI works with biopharmaceutical, medical device, diagnostic companies and CROs. We provide commercially adept medical consulting in product development, medical affairs, including medical monitoring, clinical trial planning/optimization and support a full range of medical communications. MedSurgPI physicians can serve as medical officers such as chief medical officer, or product development officer. Our team members have been involved with numerous successful US and EU product approvals. Our medical affairs team has helped marketing campaigns, both at launch and when refocusing. MedSurgPI provides a cost-effective way of having senior medical leadership on your team at critical points in your development cycle.